Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: Implications for chronic granulomatous disease

American Journal of Physiology - Cell Physiology

Volumn 297, Issue 3, 2009, Pages

  Sanmun, Duangmanee ^a,b   Witasp, Erika ^a   Jitkaew, Siriporn ^a,b   Tyurina, Yulia Y ^c   Kagan, Valerian E ^a,c   Åhlin, Anders ^d,e   Palmblad, Jan ^f   Fadeel, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d SACHS CHILDREN S HOSPITAL   (Sweden)

^e STOCKHOLM SÖDER HOSPITAL   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Inflammation; Phagocytosis; Phosphatidylserine

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLSERINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ADULT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CHRONIC GRANULOMATOUS DISEASE; CLEARANCE; COCULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; MACROPHAGE; MALE; MUTATION; NEUTROPHIL; OXIDATION; PHAGOCYTOSIS; PRIORITY JOURNAL; SURFACE PROPERTY; TARGET CELL;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CELL LINE, TUMOR; CHILD; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; MACROPHAGES; MALE; NADPH OXIDASE; NEUTROPHILS; OXIDATION-REDUCTION; PHOSPHOLIPIDS;

EID: 70349244722     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00651.2008     Document Type: Article

References (55)

1. Åhlin A, Elinder G, Palmblad J. Dose-dependent enhancements by interferon-γ on functional responses of neutrophils from chronic granulomatous disease patients. Blood 89: 3396-3401, 1997. (Pubitemid 27229827)
2. Åhlin A, Gyllenhammar H, Ringertz B, Palmblad J. Neutrophil membrane potential changes and homotypic aggregation kinetics are pH-dependent: studies of chronic granulomatous disease. J Lab Clin Med 125: 392-401, 1995.
3. 2SO-differentiated HL-60 cells. Role in phagocytic clearance. J Biol Chem 277: 49965-49975, 2002.
4. Bernuth H, Kulka C, Roesler J, Gahr M, Rosen-Wolff A. NADPH oxidase is not required for spontaneous and Staphylococcus aureus-induced apoptosis of monocytes. Ann Hematol 83: 206-211, 2004. (Pubitemid 38443504)
5. 3 synergize with 12-O-tetradecanoylphorbol-13-acetate to induce macrophage differentiation in acute promyelocytic leukemia NB4 cells. Leukemia 8: 1744-1749, 1994.
6. Brown JR, Goldblatt D, Buddle J, Morton L, Thrasher AJ. Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). J Leukoc Biol 73, 591-599, 2003. (Pubitemid 38040471)
7. Chin TW, Stiehm ER, Falloon J, Gallin JI. Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J Pediatr 111: 349-352, 1987. (Pubitemid 17157503)
8. Dibbert B, Weber M, Nikolaizik WH, Vogt P, Schoni MH, Blaser K, Simon HU. Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc Natl Acad Sci USA 96: 13330-13335, 1999.
9. phox. Blood 88: 1834-1840, 1996.
10. Donowitz GR, Mandell GL. Monocyte function in patients with chronic granulomatous disease of childhood. Blood 60: 1151-1158, 1982. (Pubitemid 13242297)
11. Ellis JA, Mayer SJ, Jones OT. The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils. Biochem J 251: 887-891, 1988.
12. Emmendorffer A, Nakamura M, Rothe G, Spiekermann K, Lohmann-Matthes ML, Roesler J. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions. Cytometry 18: 147-155, 1994. (Pubitemid 24284339)
13. Fadeel B, Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 258: 479-517, 2005. (Pubitemid 41705391)
14. Fadeel B, Åhlin A, Henter JI, Orrenius S, Hampton MB. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 92: 4808-4818, 1998. (Pubitemid 29005884)
15. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 101: 890-898, 1998. (Pubitemid 28096086)
16. Fadok VA, de Cathelineau A, Daleke DL, Henson PM, Bratton DL. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J Biol Chem 76: 1071-1077, 2001.
17. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 149: 4029-4035, 1992. (Pubitemid 23068888)
18. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2: 820-832, 2004. (Pubitemid 39317463)
19. Fernandez-Boyanapalli RF, Frasch SC, McPhillips K, Vandivier RW, Harry BL, Riches DW, Henson PM, Bratton DL. Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine- dependent production of IL-4. Blood 113: 2047-2055, 2009.
20. Goebel WS, Dinauer MC. Gene therapy for chronic granulomatous disease. Acta Haematol 110: 86-92, 2003. (Pubitemid 37340187)
21. Hampton MB, Vissers MC, Keenan JI, Winterbourn CC. Oxidant-mediated phosphatidylserine exposure and macrophage uptake of activated neutrophils: possible impairment in chronic granulomatous disease. J Leukoc Biol 71: 775-781, 2002.
22. Hartl D, Lehmann N, Hoffmann F, Jansson A, Hector A, Notheis G, Roos D, Belohradsky BH, Wintergerst U. Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease. J Allergy Clin Immunol 121: 375-382, 2008.
23. + channel. Biochem J 246: 325-329, 1987.
24. Henson PM, Tuder RM. Apoptosis in the lung: induction, clearance and detection. Am J Physiol Lung Cell Mol Physiol 294: L601-L611, 2008.
25. Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol 15: 578-584, 2003.
26. Hoidal JR, Fox RB, Repine JE. Defective oxidative metabolic responses in vitro of alveolar macrophages in chronic granulomatous disease. Am Rev Respir Dis 20: 613-618, 1979.
27. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J Clin Invest 109: 41-50, 2002.
28. Kagan VE, Gleiss B, Tyurina YY, Tyurin VA, Elenström-Magnusson C, Liu SX, Serinkan B, Arroyo A, Chandra J, Orrenius S, Fadeel B. A role for oxidative stress in apoptosis: oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. J Immunol 169: 487-499, 2002. (Pubitemid 34686171)
29. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova II, Zhao Q, Zou M, Di P, Svistunenko DA, Kurnikov IV, Borisenko GG. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1: 223-232, 2005.
30. Kasahara Y, Iwai K, Yachie A, Ohta K, Konno A, Seki H, Miyawaki T, Taniguchi N. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 89: 1748-1753, 1997. (Pubitemid 27097470)
31. Kobayashi SD, Voyich JM, Braughton KR, Whitney AR, Nauseef WM, Malech HL, DeLeo FR. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol 172: 636-643, 2004.
32. Kurosaka K, Takahashi M, Watanabe N, Kobayashi Y. Silent cleanup of very early apoptotic cells by macrophages. J Immunol 171: 4672-4679, 2003. (Pubitemid 37310584)
33. phox causes chronic granulomatous disease. J Exp Med 184: 1243-1249, 1996.
34. phox of human NADPH oxidase: consequences for oxidase assembly. Blood 95: 666-673, 2000.
35. Liu Y, Cousin JM, Hughes J, Van Damme J, Seckl JR, Haslett C, Dransfield I, Savill J, Rossi AG. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol 162: 3639-3646, 1999. (Pubitemid 29313619)
36. Maderna P, Yona S, Perretti M, Godson C. Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26). J Immunol 174: 3727-3733, 2005. (Pubitemid 40354084)
37. Mantegazza AR, Savina A, Vermeulen M, Perez L, Geffner J, Hermine O, Rosenzweig SD, Faure F, Amigorena S. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 112: 4712-4722, 2008.
38. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182: 1545-1556, 1995.
39. + conductance in neutrophils requires assembly of components of the respiratory burst oxidase but not its redox function. J Clin Invest 93: 1770-1775, 1994.
40. + conductance in NADPH oxidase-defective neutrophils. Proc Natl Acad Sci USA 90: 760-764, 1993.
41. Ren Y, Savill J. Pro-inflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J Immunol 154: 2366-2374, 1995.
42. Roos D, de Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, Åhlin A, Nemet K, Hossle JP, Bernatowska-Matuszkiewicz E, Middleton-Price H. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87: 1663-1681, 1996. (Pubitemid 26068882)
43. phox component of the phagocyte NADPH oxidase. Hum Mutat 27: 1218-1229, 2006.
44. Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol 28, Suppl 1: S67-S72, 2008.
45. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 407: 784-788, 2000. (Pubitemid 30780741)
46. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83: 865-875, 1989. (Pubitemid 19080618)
47. Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, Moura IC, Lennon-Duménil AM, Seabra MC, Raposo G, Amigorena S. NOX2 controls phagosomal pH to regulate antigen processing during cross presentation by dendritic cells. Cell 126: 205-218, 2006. (Pubitemid 44026552)
48. Scannell M, Flanagan MB, deStefani A, Wynne KJ, Cagney G, Godson C, Maderna P. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 178: 4595-4605, 2007.
49. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 6: 1191-1197, 2005. (Pubitemid 43045627)
50. Solito E, Christian HC, Festa M, Mulla A, Tierney T, Flower RJ, Buckingham JC. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J 20: 1498-1500, 2006. (Pubitemid 44943809)
51. Tyurina YY, Serinkan FB, Tyurin VA, Kini V, Yalowich JC, Schroit AJ, Fadeel B, Kagan VE. Lipid antioxidant, etoposide, inhibits phosphatidylserine externalization and macrophage clearance of apoptotic cells by preventing phosphatidylserine oxidation. J Biol Chem 279: 6056-6064, 2004. (Pubitemid 38220638)
52. van der Goes A, Brouwer J, Hoekstra K, Roos D, van den Berg TK, Dijkstra CD. Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J Neuroimmunol 92: 67-75, 1998. (Pubitemid 29015991)
53. Witasp E, Kagan V, Fadeel B. Programmed cell clearance: molecular mechanisms and role in chronic inflammation, autoimmune disease, and anti-cancer immune responses. Curr Immunol Rev 4: 53-69, 2008.
54. Yamauchi A, Kim C, Li S, Marchal CC, Towe J, Atkinson SJ, Dinauer MC. Rac2-deficient murine macrophages have selective defects in superoxide production and phagocytosis of opsonized particles. J Immunol 173: 5971-5979, 2004. (Pubitemid 39487751)
55. Zhen L, King AA, Xiao Y, Chanock SJ, Orkin SH, Dinauer MC. Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox. Proc Natl Acad Sci USA 90: 9832-9836, 1993. (Pubitemid 23328204) (Pubitemid 23970836)